BRIGHT HORIZONS for Bivalirudin? EUROMAXimizing benefits of bleeding risk but catching a MATRIX of HEAT for stent thrombosis

Indian Heart J. 2015 Jul-Aug;67(4):293-4. doi: 10.1016/j.ihj.2015.05.008. Epub 2015 Jun 22.

Authors

Jonathan Soverow¹, Ziad Ali²

Affiliations

¹ Center for Interventional Vascular Therapy, Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY, USA.
² Center for Interventional Vascular Therapy, Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY, USA; Cardiovascular Research Foundation, New York, NY, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / therapeutic use
Antithrombins / therapeutic use
Hemorrhage*
Heparin / therapeutic use
Hot Temperature*
Humans
Myocardial Infarction / drug therapy
Percutaneous Coronary Intervention
Recombinant Proteins
Stents
Thrombosis / drug therapy
Treatment Outcome

Substances

Anticoagulants
Antithrombins
Recombinant Proteins
Heparin